Reduced behavioral and neural activation in stimulant users to different error rates during decision making
Martin P Paulus1, Kathryn L Lovero, Marc Wittmann
1Laboratory of Biological Dynamics and Theoretical Medicine, Department of Psychiatry, University of California, San Diego, California, USA. mpaulus@ucsd.edu
Background:
Behavioral processes and neural systems dysfunctions that put individuals at risk for drug use in general, and stimulant use in particular, are poorly understood. Here, the hypothesis is examined that stimulant-using subjects adjust their decision making less as a function of errors as evidenced by attenuated behavioral and neural substrate activation patterns.
Methods:
Twelve young adults who had used stimulants were compared with 12 education-matched, stimulant-naive comparison subjects. Subjects completed the two-choice prediction task with three fixed error-rate conditions (20%, 50%, or 80% errors) during functional magnetic resonance imaging.
Results:
Stimulant users relative to comparison subjects showed less strategy adjustment to different error rates, for example, they were less likely to stay with winning responses (win-stay) and to shift away from losing responses (lose-shift). These subjects also showed different activation patterns as a function of error rate in left insular and bilateral dorsolateral prefrontal cortex but not anterior cingulate. The degree to which individuals adjusted switching rate, or win-stay/lose-shift consistent responses, as a function of errors was correlated with the difference in insular cortex activation differences between high and low error rates.
Conclusions:
The behavior of stimulant users is less adaptive to the frequency of errors made and fewer brain processing resources are deployed during decision making to anticipate erroneous performance. These findings could be markers for the predisposition of drug taking; however, their relevance for development of drug dependence requires further study.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists


